Allos Therapeutics Inc. has a market cap of $721.4 million; its shares were traded at around $6.94 .
ALTH is in the portfolios of George Soros of Soros Fund Management LLC, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates.
This is the annual revenues and earnings per share of ALTH over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of ALTH.
CEO Recent Trades:
- Sell:: CEO Paul L Berns sold 65,160 shares of ALTH stock on 01/08/2010 at the average price of 7, the price of the stock has decreased by 0.86% since.
This is the insider trade history vs. stock price of ALTH. For the complete insider trading history of ALTH, click here.
Directors and Officers Recent Trades:
- Buy:: VP, Pharmaceutical Operations Bruce K Jr Bennett bought 211 shares of ALTH stock on 12/31/2009 at the average price of 5.59, the price of the stock has increased by 24.15% since.
- Sell:: Director Stephen J Hoffman sold 136,286 shares of ALTH stock on 01/11/2010 at the average price of 7.06, the price of the stock has decreased by 1.7% since.
- Sell:: Director Stephen J Hoffman sold 116,285 shares of ALTH stock on 01/06/2010 at the average price of 6.67, the price of the stock has increased by 4.05% since.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.